When Evidence Falls Short-Belzutifan for Treating Tumours Associated with von Hippel-Lindau Disease: An External Assessment Group Perspective on a NICE Single Technology Appraisal.
Saved in:
| Title: | When Evidence Falls Short-Belzutifan for Treating Tumours Associated with von Hippel-Lindau Disease: An External Assessment Group Perspective on a NICE Single Technology Appraisal. |
|---|---|
| Authors: | Corro Ramos I; Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, the Netherlands. corroramos@imta.eur.nl., O'Meara S; Centre for Reviews and Dissemination, University of York, York, UK., Patel M; Kleijnen Systematic Reviews Ltd, York, UK., Stirk L; Kleijnen Systematic Reviews Ltd, York, UK., Chen J; Centre for Reviews and Dissemination, University of York, York, UK., Tian X; Kleijnen Systematic Reviews Ltd, York, UK., Armstrong N; Kleijnen Systematic Reviews Ltd, York, UK. |
| Source: | PharmacoEconomics [Pharmacoeconomics] 2025 Aug; Vol. 43 (8), pp. 845-848. Date of Electronic Publication: 2025 May 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1179-2027 |
|---|---|
| DOI: | 10.1007/s40273-025-01505-z |
